DGAP-Adhoc

Mologen AG resolves capital increase from authorized capital of up to 5,657,875 shares

MOLOGEN AG / Key word(s): Capital Increase

24.03.2015 20:57

Dissemination of an Ad hoc announcement according to § 15 WpHG, transmitted
by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

---------------------------------------------------------------------------

Mologen AG resolves capital increase from authorized capital of up to
5,657,875 shares

Berlin, 24 March 2015 - Today, the executive board of MOLOGEN AG (ISIN
DE0006637200/WKN 663720) resolved, with the approval of the supervisory
board, to increase the share capital of the company against contributions
in cash and with indirect subscription rights for existing shareholders by
partial utilization of the authorized capital pursuant to section 4 para. 3
of the articles of association (Authorized Capital 2014). Thereby, the
company's share capital is increased from EUR 16,973,626 by up to EUR
5,657,875 to up to EUR 22,631,501 against contribution in cash through the
issue of up to 5,657,875 new ordinary bearer shares with a notional value
of EUR 1.00 per share. The new shares will carry full dividend rights as of
1 January 2014.

The new shares will be subscribed for by the participating bank with the
obligation to offer the new shares to the company's shareholders for
subscription at a ratio of 1:3 (1 new share per 3 existing shares) at a yet
to be determined subscription price during a two-week subscription period.
The company will probably determine the subscription price on 30 March 2015
after closing of the stock exchange at the best possible price depending on
the market situation and in consideration of an incentivising discount in
relation to the volume weighted average share price in Xetra trading during
the last ten trading days or on the in XETRA trading lastly determined
stock price.

Subject to the approval of the securities prospectus for the rights issue
by the German Financial Supervisory Authority (BaFin), the shareholders may
exercise their subscription rights during the subscription period which is
expected to last from 7 April through 21 April 2015 (inclusive). The
shareholders will be granted the additional possibility to acquire such
shares which have not been subscribed for by other shareholders (so-called
oversubscription); however, shareholders have no legal right to claim the
allotment of such shares in the context of the oversubscription. Any new